Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Barbara Lopez, Kunz"'
Publikováno v:
Therapeutic Innovation & Regulatory Science. 55:1193-1198
Interest in patient-centric initiatives to engage patients as partners in clinical research and inform drug development strategy, planning and execution has increased exponentially during the past decade. Adoption, use, organizational approach and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca0cab26fe999d4681f06537ec5a759d
https://doi.org/10.1007/s43441-021-00289-6
https://doi.org/10.1007/s43441-021-00289-6
Publikováno v:
Therapeutic innovationregulatory science. 55(6)
Interest in patient-centric initiatives to engage patients as partners in clinical research and inform drug development strategy, planning and execution has increased exponentially during the past decade. Adoption, use, organizational approach and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a55e6401e577d9dfda2108ab0f5ca30
https://pubmed.ncbi.nlm.nih.gov/34283406
https://pubmed.ncbi.nlm.nih.gov/34283406
Publikováno v:
Clinical therapeutics. 41(8)
Purpose A growing number of biopharmaceutical companies have been implementing patient-centric initiatives (PCIs). The Drug Information Association (DIA) and the Tufts Center for the Study of Drug Development (CSDD) collaborated on a study to gather
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93820ebc3d7b79d3cbd321459a8e8d5
https://pubmed.ncbi.nlm.nih.gov/31443914
https://pubmed.ncbi.nlm.nih.gov/31443914
Autor:
Peter R. Kowey, Christopher H. Cabell, Barbara Lopez Kunz, J. Rick Turner, Mitchell W. Krucoff, Cynthia L. Green, Ignacio Rodriguez, Norman Stockbridge, John Finkle, Gary Gintant, Theressa J. Wright, Philip T. Sager, Justin Mortara
Publikováno v:
American Heart Journal. 177:96-101
The Cardiac Safety Research Consortium (CSRC), a transparent, public-private partnership established in 2005 as a Critical Path Program and formalized in 2006 under a Memorandum of Understanding between the United States Food and Drug Administration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184166c4180d76f59e03920b73d86685
https://doi.org/10.1016/j.ahj.2016.04.009
https://doi.org/10.1016/j.ahj.2016.04.009
Publikováno v:
Therapeutic innovationregulatory science. 54(1)
Recently, drug development companies have sought out patient feedback to improve overall drug development. However, characterization of the overall impact and return on engaging with patients have not been determined. The Drug Information Association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202dd56908f7e895df364b608b46231c
https://pubmed.ncbi.nlm.nih.gov/32008233
https://pubmed.ncbi.nlm.nih.gov/32008233